BioReliance opened a new clearance services facility in Rockville, MD, commissioned on August 1, which more than doubles the amount of space available to clients to conduct their downstream bioprocessing studies. The facility features four large clearance suites with modular layouts that allow for customized laboratory setups.
Several client studies and quality audits have already successfully been conducted in the new facility, according to the company. Clients have access to a range of resources, including suite-to-lounge monitoring and support from personnel. Completed studies receive a consolidated report that includes comprehensive titration and/or process data.
"It's all about simplifying the viral clearance process," said Archie Cullen, president of BioReliance. "Any time a client comes to work with us, they are assured that their study is expertly designed and performed by personnel that have participated in thousands of successful studies in support of clinical and commercial biopharmaceutical products."
In January 2012, Sigma-Aldrich acquired BioReliance for $350 million in cash.